81 related articles for article (PubMed ID: 26548424)
1. Predictive validation of modeled health technology assessment claims: lessons from NICE.
Belsey J
J Med Econ; 2015; 18(12):1007-12. PubMed ID: 26548424
[TBL] [Abstract][Full Text] [Related]
2. The status of modeled claims.
Langley PC
J Med Econ; 2015; 18(12):991-2. PubMed ID: 26549706
[TBL] [Abstract][Full Text] [Related]
3. Validation of modeled pharmacoeconomic claims in formulary submissions.
Langley PC
J Med Econ; 2015; 18(12):993-9. PubMed ID: 26549802
[TBL] [Abstract][Full Text] [Related]
4. Drug prices and value for money: the Australian Pharmaceutical Benefits Scheme.
Henry DA; Hill SR; Harris A
JAMA; 2005 Nov; 294(20):2630-2. PubMed ID: 16304078
[No Abstract] [Full Text] [Related]
5. A cure for old age. Why NHS must act now to save the deteriorating asset base.
Health Serv J; 2013 Nov; 123(6376):19. PubMed ID: 24416973
[No Abstract] [Full Text] [Related]
6. Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals.
Bryan S; Williams I; McIver S
Health Econ; 2007 Feb; 16(2):179-93. PubMed ID: 16960851
[TBL] [Abstract][Full Text] [Related]
7. Lansley is right: age trumps poverty.
Asthana S
Health Serv J; 2012 May; 122(6306):16-7. PubMed ID: 22741385
[No Abstract] [Full Text] [Related]
8. The NHS must build resilience.
Heitmueller A
Health Serv J; 2014 May; 124(6400):16-8. PubMed ID: 25137754
[No Abstract] [Full Text] [Related]
9. Prioritizing health technologies in a Primary Care Trust.
Wilson E; Sussex J; Macleod C; Fordham R
J Health Serv Res Policy; 2007 Apr; 12(2):80-5. PubMed ID: 17407656
[TBL] [Abstract][Full Text] [Related]
10. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
Williams I; Bryan S; McIver S
J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
[TBL] [Abstract][Full Text] [Related]
11. Disinvestment from low value clinical interventions: NICEly done?
Garner S; Littlejohns P
BMJ; 2011 Jul; 343():d4519. PubMed ID: 21795239
[No Abstract] [Full Text] [Related]
12. AHRQ's free research can help plans anticipate coverage issues.
Roberts DC; Schoelles K
Manag Care; 2013 Oct; 22(10):41-4. PubMed ID: 24344527
[No Abstract] [Full Text] [Related]
13. Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making.
Andronis L; Barton P; Bryan S
Health Technol Assess; 2009 Jun; 13(29):iii, ix-xi, 1-61. PubMed ID: 19500484
[TBL] [Abstract][Full Text] [Related]
14. The role of NICE technology appraisal in NHS rationing.
Walker S; Palmer S; Sculpher M
Br Med Bull; 2007; 81-82():51-64. PubMed ID: 17409119
[TBL] [Abstract][Full Text] [Related]
15. Choosing between competing health priorities. A government payer perspective.
Leese J
Pharmacoeconomics; 1996; 9 Suppl 3():4-7; discussion 23-5. PubMed ID: 10160486
[TBL] [Abstract][Full Text] [Related]
16. PRIORITIES FOR HEALTH ECONOMIC METHODOLOGICAL RESEARCH: RESULTS OF AN EXPERT CONSULTATION.
Tordrup D; Chouaid C; Cuijpers P; Dab W; van Dongen JM; Espin J; Jönsson B; Léonard C; McDaid D; McKee M; Miguel JP; Patel A; Reginster JY; Ricciardi W; Rutten-van Molken M; Rupel VP; Sach T; Sassi F; Waugh N; Bertollini R
Int J Technol Assess Health Care; 2017 Jan; 33(6):609-619. PubMed ID: 29081308
[TBL] [Abstract][Full Text] [Related]
17. Translational health economics: The key to accountable adoption of in vitro diagnostic technologies.
Price CP; Wolstenholme J; McGinley P; St John A
Health Serv Manage Res; 2018 Feb; 31(1):43-50. PubMed ID: 29084478
[TBL] [Abstract][Full Text] [Related]
18. Quality, innovation, and value for money: NICE and the British National Health Service.
Pearson SD; Rawlins MD
JAMA; 2005 Nov; 294(20):2618-22. PubMed ID: 16304076
[TBL] [Abstract][Full Text] [Related]
19. What you don't know can't hurt you? Statistical issues and standards for medical technology evaluation.
Mullahy J
Med Care; 1996 Dec; 34(12 Suppl):DS124-35. PubMed ID: 8969321
[No Abstract] [Full Text] [Related]
20. Defining types of economic evaluation.
Ngorsuraches S
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S21-7. PubMed ID: 19255985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]